Dietary Enrichment with Medium Chain Triglycerides (AC-1203) Elevates Polyunsaturated Fatty Acids in the Parietal Cortex of Aged Dogs: Implications for Treating Age-Related Cognitive Decline
- 442 Downloads
Dogs demonstrate an age-related cognitive decline, which may be related to a decrease in the concentration of omega-3 polyunsaturated fatty acids (n-3 PUFA) in the brain. Medium chain triglycerides (MCT) increase fatty acid oxidation, and it has been suggested that this may raise brain n-3 PUFA levels by increasing mobilization of n-3 PUFA from adipose tissue to the brain. The goal of the present study was to determine whether dietary MCT would raise n-3 PUFA concentrations in the brains of aged dogs. Eight Beagle dogs were randomized to a control diet (n = 4) or an MCT (AC-1203) enriched diet (n = 4) for 2 months. The animals were then euthanized and the parietal cortex was removed for phospholipid, cholesterol and fatty acid determinations by gas-chromatography. Dietary enrichment with MCT (AC-1203) resulted in a significant increase in brain phospholipid and total lipid concentrations (P < 0.05). In particular, n-3 PUFA within the phospholipid, unesterified fatty acid, and total lipid fractions were elevated in AC-1203 treated subjects as compared to controls (P < 0.05). Brain cholesterol concentrations did not differ significantly between the groups (P > 0.05). These results indicate that dietary enrichment with MCT, raises n-3 PUFA concentrations in the parietal cortex of aged dogs.
KeywordsMedium chain triglycerides Brain Omega-3 polyunsaturated fatty acids (n-3 PUFA) Docosahexaenoic acid (DHA) Mobilization Cognition Alzheimer’s Aging Dogs
Medium chain triglycerides
Polyunsaturated fatty acids
We would like to thank Dr. Christa M. Studzinski for her assistance and Dr. David W.L. Ma for his support and expert advice. Financial support for this study was provided by the Natural Sciences and Engineering Research Council and Accera Inc. A.Y.T is a recipient of the Canadian Institutes of Health Research Doctoral Research Award (Fredrick Banting and Charles Best Canada Graduate Scholarships). The authors declare no conflict of interest.
- 4.Studzinski CM, Araujo JA, Milgram NW (2005) The canine model of human cognitive aging and dementia: pharmacological validity of the model for assessment of human cognitive-enhancing drugs. Prog Neuropsychopharmacol Biol Psychiatry 29:489–498. doi: 10.1016/j.pnpbp.2004.12.014 PubMedCrossRefGoogle Scholar
- 14.Demar JC Jr, Ma K, Chang L, Bell JM, Rapoport SI (2005) alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J Neurochem 94:1063–1076. doi: 10.1111/j.1471-4159.2005.03258.x PubMedCrossRefGoogle Scholar
- 17.Studzinski CM, MacKay WA, Beckett TL, Henderson ST, Murphy MP, Sullivan PG et al (2008) Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-beta precursor protein (APP) levels in the aged dog. Brain Res 1226:209–217. doi: 10.1016/j.brainres.2008.06.005 PubMedCrossRefGoogle Scholar
- 18.Barcelo-Coblijn G, Hogyes E, Kitajka K, Puskas LG, Zvara A, Hackler L Jr et al (2003) Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci USA 100:11321–11326. doi: 10.1073/pnas.1734008100 PubMedCrossRefGoogle Scholar
- 29.Farasat S, Kossoff EH, Pillas DJ, Rubenstein JE, Vining EP, Freeman JM (2006) The importance of parental expectations of cognitive improvement for their children with epilepsy prior to starting the ketogenic diet. Epilepsy Behav 8:406–410. doi: 10.1016/j.yebeh.2005.12.002 PubMedCrossRefGoogle Scholar